Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by retiredcfon Oct 03, 2022 7:59am
168 Views
Post# 35000998

Scotia Capital

Scotia CapitalThis new analyst reduced the targets for a multitude of companies. GLTA

In a series of research reports released Monday, Scotia Capital analyst George Doumet assumed the firm’s consumer products coverage following the retirement of colleague Patricia Baker.

Neighbourly Pharmacy Inc. 

increase
 
( “sector outperform”) to $25 from $30. Average: $29.30.

“When compared to its Canadian consolidator peers, NBLY boasts one of the highest EBITDA/share CAGRs from 2020 to 2023,” he said. “NBLY is currently trading at 10.7 times our F24 estimates. We believe a premium to its consolidation peers is warranted given NBLY’s stronger growth profile, its more defensive business model and its stronger FCF generation.”

<< Previous
Bullboard Posts
Next >>